{"title":"Leadless pacing in peri-procedural settings.","authors":"Mikhael F El-Chami, Ryan Cunnane","doi":"10.1093/eurheartjsupp/suae093","DOIUrl":null,"url":null,"abstract":"<p><p>Leadless pacemakers' (LPs) main advantage over the traditional transvenous permanent pacemakers (TV-PPMs) is the absence of leads and subcutaneous pocket. These intracardiac pacemakers have been shown in observational studies to reduce long-term complications as compared with TV-PPM mainly by reducing the need for re-intervention. Two major advantages of this technology are the lower rate of infection (absence of pocket and lower rate of bacterial seeding) and lead-related complications (dislodgment). Hence, these advantages are more accentuated after transcutaneous valve replacement or valve surgery and clinical situations where it is important to reduce systemic infections and endocarditis. In this review, we highlight the role of LP in patients after transcutaneous and surgical valve replacements.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"27 Suppl 2","pages":"ii21-ii25"},"PeriodicalIF":1.7000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11932075/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal Supplements","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartjsupp/suae093","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Leadless pacemakers' (LPs) main advantage over the traditional transvenous permanent pacemakers (TV-PPMs) is the absence of leads and subcutaneous pocket. These intracardiac pacemakers have been shown in observational studies to reduce long-term complications as compared with TV-PPM mainly by reducing the need for re-intervention. Two major advantages of this technology are the lower rate of infection (absence of pocket and lower rate of bacterial seeding) and lead-related complications (dislodgment). Hence, these advantages are more accentuated after transcutaneous valve replacement or valve surgery and clinical situations where it is important to reduce systemic infections and endocarditis. In this review, we highlight the role of LP in patients after transcutaneous and surgical valve replacements.
期刊介绍：
The European Heart Journal Supplements (EHJs) is a long standing member of the ESC Journal Family that serves as a publication medium for supplemental issues of the flagship European Heart Journal. Traditionally EHJs published a broad range of articles from symposia to special issues on specific topics of interest.
The Editor-in-Chief, Professor Roberto Ferrari, together with his team of eminent Associate Editors: Professor Francisco Fernández-Avilés, Professors Jeroen Bax, Michael Böhm, Frank Ruschitzka, and Thomas Lüscher from the European Heart Journal, has implemented a change of focus for the journal. This entirely refreshed version of the European Heart Journal Supplements now bears the subtitle the Heart of the Matter to give recognition to the focus the journal now has.
The EHJs – the Heart of the Matter intends to offer a dedicated, scientific space for the ESC, Institutions, National and Affiliate Societies, Associations, Working Groups and Councils to disseminate their important successes globally.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
